The global Viral Vector-Based Gene Therapy market growth is projected to reach US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Global Viral Vector-Based Gene Therapy Market Trends And Outlook 2025-31

The global Viral Vector-Based Gene Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Viral Vector-Based Gene Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Viral Vector-Based Gene Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Viral Vector-Based Gene Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Viral Vector-Based Gene Therapy players cover Sibiono, Rigvir Group, Shanghai Pharma (Sunway), Amgen, Spark Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. LPI (LP Information) newest research report, the ?Viral Vector-Based Gene Therapy Industry Forecast? looks at past sales and reviews total world Viral Vector-Based Gene Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Viral Vector-Based Gene Therapy sales for 2025 through 2031. With Viral Vector-Based Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Vector-Based Gene Therapy industry. This Insight Report provides a comprehensive analysis of the global Viral Vector-Based Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Viral Vector-Based Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Viral Vector-Based Gene Therapy market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Vector-Based Gene Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Vector-Based Gene Therapy. This report presents a comprehensive overview, market shares, and growth opportunities of Viral Vector-Based Gene Therapy market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Adenovirus (AdV) &nbsp;&nbsp;&nbsp; Adeno-associated Virus (AAV) Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Clinic &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Sibiono &nbsp;&nbsp;&nbsp; Rigvir Group &nbsp;&nbsp;&nbsp; Shanghai Pharma (Sunway) &nbsp;&nbsp;&nbsp; Amgen &nbsp;&nbsp;&nbsp; Spark Therapeutics &nbsp;&nbsp;&nbsp; Novartis Gene Therapies &nbsp;&nbsp;&nbsp; Daiichi Sankyo &nbsp;&nbsp;&nbsp; PTC Therapeutics

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Viral Vector-Based Gene Therapy Market Size (2020-2031) &nbsp;2.1.2 Viral Vector-Based Gene Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Viral Vector-Based Gene Therapy by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Viral Vector-Based Gene Therapy Segment by Type &nbsp;2.2.1 Adenovirus (AdV) &nbsp;2.2.2 Adeno-associated Virus (AAV) &nbsp;2.3 Viral Vector-Based Gene Therapy Market Size by Type &nbsp;2.3.1 Viral Vector-Based Gene Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Viral Vector-Based Gene Therapy Market Size Market Share by Type (2020-2025) &nbsp;2.4 Viral Vector-Based Gene Therapy Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Clinic &nbsp;2.4.3 Others &nbsp;2.5 Viral Vector-Based Gene Therapy Market Size by Application &nbsp;2.5.1 Viral Vector-Based Gene Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Viral Vector-Based Gene Therapy Market Size Market Share by Application (2020-2025) 3 Viral Vector-Based Gene Therapy Market Size by Player &nbsp;3.1 Viral Vector-Based Gene Therapy Market Size Market Share by Player &nbsp;3.1.1 Global Viral Vector-Based Gene Therapy Revenue by Player (2020-2025) &nbsp;3.1.2 Global Viral Vector-Based Gene Therapy Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Viral Vector-Based Gene Therapy Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Viral Vector-Based Gene Therapy by Region &nbsp;4.1 Viral Vector-Based Gene Therapy Market Size by Region (2020-2025) &nbsp;4.2 Global Viral Vector-Based Gene Therapy Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Viral Vector-Based Gene Therapy Market Size Growth (2020-2025) &nbsp;4.4 APAC Viral Vector-Based Gene Therapy Market Size Growth (2020-2025) &nbsp;4.5 Europe Viral Vector-Based Gene Therapy Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Viral Vector-Based Gene Therapy Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Viral Vector-Based Gene Therapy Market Size by Country (2020-2025) &nbsp;5.2 Americas Viral Vector-Based Gene Therapy Market Size by Type (2020-2025) &nbsp;5.3 Americas Viral Vector-Based Gene Therapy Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Viral Vector-Based Gene Therapy Market Size by Region (2020-2025) &nbsp;6.2 APAC Viral Vector-Based Gene Therapy Market Size by Type (2020-2025) &nbsp;6.3 APAC Viral Vector-Based Gene Therapy Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Viral Vector-Based Gene Therapy Market Size by Country (2020-2025) &nbsp;7.2 Europe Viral Vector-Based Gene Therapy Market Size by Type (2020-2025) &nbsp;7.3 Europe Viral Vector-Based Gene Therapy Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Viral Vector-Based Gene Therapy by Region (2020-2025) &nbsp;8.2 Middle East & Africa Viral Vector-Based Gene Therapy Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Viral Vector-Based Gene Therapy Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Viral Vector-Based Gene Therapy Market Forecast &nbsp;10.1 Global Viral Vector-Based Gene Therapy Forecast by Region (2026-2031) &nbsp;10.1.1 Global Viral Vector-Based Gene Therapy Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Viral Vector-Based Gene Therapy Forecast &nbsp;10.1.3 APAC Viral Vector-Based Gene Therapy Forecast &nbsp;10.1.4 Europe Viral Vector-Based Gene Therapy Forecast &nbsp;10.1.5 Middle East & Africa Viral Vector-Based Gene Therapy Forecast &nbsp;10.2 Americas Viral Vector-Based Gene Therapy Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.2.2 Canada Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.2.3 Mexico Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.2.4 Brazil Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.3 APAC Viral Vector-Based Gene Therapy Forecast by Region (2026-2031) &nbsp;10.3.1 China Viral Vector-Based Gene Therapy Market Forecast &nbsp;10.3.2 Japan Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.3.3 Korea Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.3.4 Southeast Asia Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.3.5 India Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.3.6 Australia Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.4 Europe Viral Vector-Based Gene Therapy Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.4.2 France Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.4.3 UK Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.4.4 Italy Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.4.5 Russia Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.5 Middle East & Africa Viral Vector-Based Gene Therapy Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.5.2 South Africa Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.5.3 Israel Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.5.4 Turkey Market Viral Vector-Based Gene Therapy Forecast &nbsp;10.6 Global Viral Vector-Based Gene Therapy Forecast by Type (2026-2031) &nbsp;10.7 Global Viral Vector-Based Gene Therapy Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Viral Vector-Based Gene Therapy Forecast 11 Key Players Analysis &nbsp;11.1 Sibiono &nbsp;11.1.1 Sibiono Company Information &nbsp;11.1.2 Sibiono Viral Vector-Based Gene Therapy Product Offered &nbsp;11.1.3 Sibiono Viral Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Sibiono Main Business Overview &nbsp;11.1.5 Sibiono Latest Developments &nbsp;11.2 Rigvir Group &nbsp;11.2.1 Rigvir Group Company Information &nbsp;11.2.2 Rigvir Group Viral Vector-Based Gene Therapy Product Offered &nbsp;11.2.3 Rigvir Group Viral Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Rigvir Group Main Business Overview &nbsp;11.2.5 Rigvir Group Latest Developments &nbsp;11.3 Shanghai Pharma (Sunway) &nbsp;11.3.1 Shanghai Pharma (Sunway) Company Information &nbsp;11.3.2 Shanghai Pharma (Sunway) Viral Vector-Based Gene Therapy Product Offered &nbsp;11.3.3 Shanghai Pharma (Sunway) Viral Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Shanghai Pharma (Sunway) Main Business Overview &nbsp;11.3.5 Shanghai Pharma (Sunway) Latest Developments &nbsp;11.4 Amgen &nbsp;11.4.1 Amgen Company Information &nbsp;11.4.2 Amgen Viral Vector-Based Gene Therapy Product Offered &nbsp;11.4.3 Amgen Viral Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Amgen Main Business Overview &nbsp;11.4.5 Amgen Latest Developments &nbsp;11.5 Spark Therapeutics &nbsp;11.5.1 Spark Therapeutics Company Information &nbsp;11.5.2 Spark Therapeutics Viral Vector-Based Gene Therapy Product Offered &nbsp;11.5.3 Spark Therapeutics Viral Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Spark Therapeutics Main Business Overview &nbsp;11.5.5 Spark Therapeutics Latest Developments &nbsp;11.6 Novartis Gene Therapies &nbsp;11.6.1 Novartis Gene Therapies Company Information &nbsp;11.6.2 Novartis Gene Therapies Viral Vector-Based Gene Therapy Product Offered &nbsp;11.6.3 Novartis Gene Therapies Viral Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Novartis Gene Therapies Main Business Overview &nbsp;11.6.5 Novartis Gene Therapies Latest Developments &nbsp;11.7 Daiichi Sankyo &nbsp;11.7.1 Daiichi Sankyo Company Information &nbsp;11.7.2 Daiichi Sankyo Viral Vector-Based Gene Therapy Product Offered &nbsp;11.7.3 Daiichi Sankyo Viral Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Daiichi Sankyo Main Business Overview &nbsp;11.7.5 Daiichi Sankyo Latest Developments &nbsp;11.8 PTC Therapeutics &nbsp;11.8.1 PTC Therapeutics Company Information &nbsp;11.8.2 PTC Therapeutics Viral Vector-Based Gene Therapy Product Offered &nbsp;11.8.3 PTC Therapeutics Viral Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 PTC Therapeutics Main Business Overview &nbsp;11.8.5 PTC Therapeutics Latest Developments 12 Research Findings and Conclusion

Report	Global Viral Vector-Based Gene Therapy Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI10805

Buyer Information

Order Summary